A new study has found that Ezetimibe can reduce the cardiovascular problems in diabetes patients. The drug achieved greater reductions in LDL cholesterol than statins alone, resulting in lower risks of cardiovascular events in patients with diabetes and the benefits observed in diabetics were greater than in those without diabetes.
If you are taking statins, there's no need to worry as a new study has suggested that the cholesterol-lowering drugs most likely do not cause short-term memory loss.Lead study author Brian L. Strom of Rutgers University said that limited previous studies and some statin-drug takers have anecdotally reported memory lapses after taking popular lipid-lowering drugs (LLDs) called statins. The result has been that some people have stopped taking their statins, inappropriately.The study compared new users of statins with people not taking statins. New statin users also were compared to a second control group - patients taking nonstatin LLDs, which had not been done before.More patients taking statins indeed reported memory loss in the 30-day period after first taking the drugs, compared to non-users, the study found. The same, however, was found with the nonstatin LLDs.Either it means that anything that lowers cholesterol has the same effect on short-term memory, which is not scientifically credible because you're dealing with drugs with completely different structures, Strom noted, adding that detection bias is more likely the reason, meaning patients taking a new drug visit their doctors more frequently and are highly attuned to their health.Strom added that when patients are put on statins or any new drug, they're seen more often by their doctor or they themselves are paying attention to whether anything is wrong. So if they have a memory problem, they're going to notice it.He continued that even if it has nothing to do with the drug, they're going to blame it on the drug.Strom concluded that people who have high cholesterol should be on statins, which include atorvastatin, cerivastatin, fluvastatin, pravastatin and simvastatin, while nonstatin LLDs include cholestyramine, colestipol hydrochloride, colesevelam, clofibrate and gemfibrozil, are a very effective therapy, which is very safe.The study appears in The Journal of the American Medical Association-Internal Medicine.
a new research, which suggests that drugs for high cholesterol or statins don't really impair memory and cognitive function, has cast doubts on the cautionary stance taken by the US Food and Drug Agency (FDA).
Contrary to prevalent suggestions that statin users may have a reduced risk of fractures, researchers have found that treatment with an anti-cholesterol medicine did not reduce the risk of fracture among men and women.